Personalized treatments have the greatest potential to benefit cancer patients. Guided selection of the most suitable drug or combination of drugs for a specific patient’s cancer profile avoids a trial-and-error treatment strategy.
In this context, many university hospitals house dedicated research groups to screen small, dedicated drug libraries on primary tumor cells derived from patient biopsies to match potential treatments to different cancer types.
In this eBook we have compiled examples of such laboratories working in the area of pediatric oncology. They all share a reliance on miniaturization and fast processing times to screen hundreds of compounds on very limited and precious patient material.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
